130 related articles for article (PubMed ID: 8264505)
1. Drugs for vomiting caused by cancer chemotherapy.
Med Lett Drugs Ther; 1993 Dec; 35(912):124-6. PubMed ID: 8264505
[No Abstract] [Full Text] [Related]
2. Comparison of ondansetron-dexamethasone-lorazepam versus metoclopramide-dexamethasone-lorazepam in the control of cisplatin induced emesis.
Manusirivithaya S; Chareoniam V; Isariyodom P; Sungsab D
J Med Assoc Thai; 2001 Jul; 84(7):966-72. PubMed ID: 11759977
[TBL] [Abstract][Full Text] [Related]
3. Ondansetron to prevent vomiting after cancer chemotherapy.
Med Lett Drugs Ther; 1991 Jun; 33(847):63-4. PubMed ID: 1828531
[No Abstract] [Full Text] [Related]
4. Prevention of delayed emesis caused by chemotherapy.
Harmon D; O'Brien B
N Engl J Med; 2000 Sep; 343(12):889; author reply 889-90. PubMed ID: 11001695
[No Abstract] [Full Text] [Related]
5. The influence of dexamethasone in the decrease of chemotherapy-induced nausea and vomiting.
Sarcev T; Secen N; Povazan Dj; Sabo A; Popovic J; Bursac D; Kakas M; Zaric B; Milovancev A
J BUON; 2007; 12(2):245-52. PubMed ID: 17600880
[TBL] [Abstract][Full Text] [Related]
6. [Clinical studies of oral antiemetic drugs on delayed emesis induced by cancer chemotherapy].
Sawaguchi K; Yabushita H; Tsukada H; Yamada H; Noguchi M; Nakanishi M
Gan To Kagaku Ryoho; 1999 Jan; 26(1):117-23. PubMed ID: 9987507
[TBL] [Abstract][Full Text] [Related]
7. Prevention of cisplatin-induced delayed emesis: still unsatisfactory. Italian Group for Antiemetic Research.
Support Care Cancer; 2000 May; 8(3):229-32. PubMed ID: 10789965
[TBL] [Abstract][Full Text] [Related]
8. Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.
Sorbe BG
Semin Oncol; 1994 Oct; 21(5 Suppl 9):20-6. PubMed ID: 9113123
[TBL] [Abstract][Full Text] [Related]
9. Ondansetron to prevent chemotherapy-induced vomiting.
Drug Ther Bull; 1992 Mar; 30(6):21-3. PubMed ID: 1534293
[No Abstract] [Full Text] [Related]
10. [Comparative trial between two drugs in the treatment of vomiting induced by anti-cancer chemotherapy (author's transl)].
Zylberait D; Krulik M; Audebert AA; Debray J
Sem Hop; 1981 Jan 8-15; 57(1-2):47-9. PubMed ID: 6258237
[TBL] [Abstract][Full Text] [Related]
11. The antiemetic efficacy of oral ondansetron plus intravenous dexamethasone in patients with gynecologic malignancies receiving carboplatin-based chemotherapy.
Markman M; Kennedy A; Webster K; Peterson G; Kulp B; Belinson J
Gynecol Oncol; 2000 Jul; 78(1):43-6. PubMed ID: 10873408
[TBL] [Abstract][Full Text] [Related]
12. Freeze dried ondansetron: first observations with the fast dissolving oral antiemetic Zofran Zydis for the prophylaxis of the cisplatin-induced emesis in gynecological cancer patients.
Lehoczky O; Udvary J; Pulay T
Neoplasma; 2002; 49(2):126-8. PubMed ID: 12088106
[TBL] [Abstract][Full Text] [Related]
13. Ondansetron as an antiemetic.
Reed MD
Br J Clin Pharmacol; 1992 Aug; 34(2):144. PubMed ID: 1419476
[No Abstract] [Full Text] [Related]
14. Palonosetron: a unique 5-HT3 receptor antagonist indicated for the prevention of acute and delayed chemotherapy-induced nausea and vomiting.
Rubenstein EB
Clin Adv Hematol Oncol; 2004 May; 2(5):284-9. PubMed ID: 16163194
[TBL] [Abstract][Full Text] [Related]
15. Fighting nausea in the '90s: more and better anti-emetics can help.
Saphir A
J Natl Cancer Inst; 1997 Sep; 89(17):1252-5. PubMed ID: 9293911
[No Abstract] [Full Text] [Related]
16. Comparison of dexamethasone and metoclopramide as antiemetics in children receiving cancer chemotherapy.
Basade M; Kulkarni SS; Dhar AK; Sastry PS; Saikia B; Advani SH
Indian Pediatr; 1996 Apr; 33(4):321-3. PubMed ID: 8772908
[No Abstract] [Full Text] [Related]
17. Antiemetic effect of ondansetron and dexamethasone in gynecologic malignant patients receiving chemotherapy.
Pradermdee P; Manusirivithaya S; Tangjitgamol S; Thavaramara T; Sukwattana P
J Med Assoc Thai; 2006 Oct; 89 Suppl 4():S29-36. PubMed ID: 17725140
[TBL] [Abstract][Full Text] [Related]
18. Prevention of chemotherapy-induced nausea and vomiting by tropisetron (Navoban) alone or in combination with other antiemetic agents.
Bruntsch U; Drechsler S; Eggert J; Gosse H; Ukena D; Imhoff W; Faerber L
Semin Oncol; 1994 Oct; 21(5 Suppl 9):7-11. PubMed ID: 9113120
[TBL] [Abstract][Full Text] [Related]
19. Preventing emesis in lung cancer patients.
J Support Oncol; 2007 Feb; 5(2):79-80. PubMed ID: 17348365
[No Abstract] [Full Text] [Related]
20. [Use of ondansetron, a 5-HT3 receptor antagonist, as a new type of antiemetic in pediatric oncology].
Csáki C; Ferencz T; Koós R; Schuler D; Borsi J
Orv Hetil; 1993 Jun; 134(25):1363-7. PubMed ID: 8332356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
